M T Bruun1, K Pendry2,3, J Georgsen1, P Manzini4, M Lorenzi4, A Wikman5, D Borg-Aquilina6, E van Pampus7, M van Kraaij8, D Fischer9, P Meybohm9, K Zacharowski9, C Geisen10, E Seifried10, G M Liumbruno11, G Folléa12, J Grant-Casey3, P Babra3, M F Murphy3,13,14. 1. Department of Clinical Immunology, Odense University Hospital, Odense, Denmark. 2. Department of Transfusion, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK. 3. NHS Blood & Transplant, Manchester, UK. 4. Banca del Sangue e del Plasma CPVE, Città della Salute e della Scienza di Torino, Torino, Italy. 5. Department of Clinical Immunology and Transfusion Medicine, Karolinska University Hospital, Stockholm, Sweden. 6. Hospital Blood Bank, Mater Dei University Hospital, Msida, Malta. 7. Laboratory of Medical Immunology, Radboud University Medical Centre, Nijmegen, The Netherlands. 8. Department of Transfusion Medicine, Sanquin Blood Bank, Amsterdam, The Netherlands. 9. Department of Anaesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt, Frankfurt, Germany. 10. German Red Cross Blood Service Baden-Wuerttemberg-Hessen, Institute of Transfusion Medicine and Immunohaematology, Frankfurt, Germany. 11. Italian National Blood Centre, National Institute of Health, Rome, Italy. 12. European Blood Alliance, Amsterdam, The Netherlands. 13. Oxford University Hospitals NHS Foundation Trust, Oxford, UK. 14. University of Oxford, Oxford, UK.
Abstract
BACKGROUND AND OBJECTIVES: Patient Blood Management (PBM) in Europe is a working group of the European Blood Alliance with the initial objective to identify the starting position of the participating hospitals regarding PBM for benchmarking purposes, and to derive good practices in PBM from the experience and expertise in the participating teams with the further aim of implementing and strengthening these practices in the participating hospitals. METHODS: We conducted two surveys in seven university hospitals in Europe: Survey on top indications for red blood cell use regarding usage of red blood cells during 1 week and Survey on PBM organization and activities. RESULTS: A total of 3320 units of red blood cells were transfused in 1 week at the seven hospitals. Overall, 61% of red cell units were transfused to medical patients and 36% to surgical patients, although there was much variation between hospitals. The organization and activities of PBM in the seven hospitals were variable, but there was a common focus on optimizing the treatment of bleeding patients, monitoring the use of blood components and treatment of preoperative anaemia. CONCLUSION: Although the seven hospitals provide a similar range of clinical services, there was variation in transfusion rates between them. Further, there was variable implementation of PBM activities and monitoring of transfusion practice. These findings provide a baseline to develop joint action plans to further implement and strengthen PBM across a number of hospitals in Europe.
BACKGROUND AND OBJECTIVES:Patient Blood Management (PBM) in Europe is a working group of the European Blood Alliance with the initial objective to identify the starting position of the participating hospitals regarding PBM for benchmarking purposes, and to derive good practices in PBM from the experience and expertise in the participating teams with the further aim of implementing and strengthening these practices in the participating hospitals. METHODS: We conducted two surveys in seven university hospitals in Europe: Survey on top indications for red blood cell use regarding usage of red blood cells during 1 week and Survey on PBM organization and activities. RESULTS: A total of 3320 units of red blood cells were transfused in 1 week at the seven hospitals. Overall, 61% of red cell units were transfused to medical patients and 36% to surgical patients, although there was much variation between hospitals. The organization and activities of PBM in the seven hospitals were variable, but there was a common focus on optimizing the treatment of bleedingpatients, monitoring the use of blood components and treatment of preoperative anaemia. CONCLUSION: Although the seven hospitals provide a similar range of clinical services, there was variation in transfusion rates between them. Further, there was variable implementation of PBM activities and monitoring of transfusion practice. These findings provide a baseline to develop joint action plans to further implement and strengthen PBM across a number of hospitals in Europe.
Authors: Hermann Eichler; Anna Katharina Feyer; Kerstin Weitmann; Wolfgang Hoffmann; Olaf Henseler; Andreas Opitz; Alexander Patek; Detlef Nikolaus Hans; Linda Schönborn; Andreas Greinacher Journal: Transfus Med Hemother Date: 2020-12-23 Impact factor: 3.747
Authors: Loan R van Hoeven; Aukje L Kreuger; Kit Cb Roes; Peter F Kemper; Hendrik Koffijberg; Floris J Kranenburg; Jan Mm Rondeel; Mart P Janssen Journal: Clin Epidemiol Date: 2018-03-29 Impact factor: 4.790
Authors: Gustavo de Carvalho Duarte; Francisco Guilherme Fujita Neto; José Francisco Comenalli Marques Júnior; Dante Mario Langhi Journal: Hematol Transfus Cell Ther Date: 2021-03-14